Monday's Breakfast Briefing: What's next for the AT&T-DirecTV deal

Everything you need to know to start your day.

AT&T to acquire DirecTV. Here's what's next:
AT&T agreed to buy DirecTV for $48.5 billion on Sunday, changing the pay-TV landscape even further after the Comcast-Time Warner merger pact that was struck in February.
Why the deal makes sense for AT&T:

Here’s what happens next:

AstraZeneca rejects ‘final’ Pfizer bid
British drugmaker AstraZeneca rejected Pfizer’s "final" $117 billion acquisition bid on Monday morning, calling it inadequate and leaving the two companies at a stalemate. AstraZeneca’s share price dropped as investors took the decision as the end of any possible deal.

Abramson to speak publicly for first time since firing
Jill Abramson will make her first public remarks since she was ousted from the top editorial job at The New York Times last week when she delivers the commencement address at Wake Forest University on Monday. Despite a deluge of conflicting reports about the reasons for her exit, it is unclear whether she will address the situation.

Outrage grows over VA wait times
Calls for Veterans Affairs Secretary Eric Shinseki to resign grew louder over the weekend as new details emerged about long wait times for care for veterans with serious medical conditions in the VA health system. White House chief of staff Denis McDonough said President Barack Obama is "madder than hell" about the issue.

Clinton’s age, health are fair game
Whether or not former Secretary of State Hillary Rodham Clinton will run for president is the biggest of all 2016 rumors. With that in mind, Republican National Committee chairman Reince Priebus said Sunday that the former first lady’s health and age — she’d take office at age 69  — are fair game for Republicans. GOP strategist Karl Rove was widely criticized after questioning whether Clinton suffered brain damage last week after a late 2012 fall.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.